KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Intangibles (2020 - 2025)

Ginkgo Bioworks Holdings' Intangibles history spans 6 years, with the latest figure at $56.9 million for Q4 2025.

  • For Q4 2025, Intangibles fell 21.49% year-over-year to $56.9 million; the TTM value through Dec 2025 reached $56.9 million, down 21.49%, while the annual FY2025 figure was $56.9 million, 21.49% down from the prior year.
  • Intangibles reached $56.9 million in Q4 2025 per DNA's latest filing, down from $61.5 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $111.0 million in Q4 2022 to a low of $20.8 million in Q1 2022.
  • Average Intangibles over 5 years is $68.5 million, with a median of $70.6 million recorded in 2024.
  • Peak YoY movement for Intangibles: surged 557.01% in 2021, then fell 28.81% in 2024.
  • A 5-year view of Intangibles shows it stood at $21.6 million in 2021, then soared by 413.08% to $111.0 million in 2022, then fell by 25.49% to $82.7 million in 2023, then dropped by 12.37% to $72.5 million in 2024, then decreased by 21.49% to $56.9 million in 2025.
  • Per Business Quant, the three most recent readings for DNA's Intangibles are $56.9 million (Q4 2025), $61.5 million (Q3 2025), and $66.2 million (Q2 2025).